The data presented in this study highlight the involvement of JNK3 in incretin responses in both in vivo mouse models and human islets, suggesting the importance of JNK3 in human β cell biology and its potential as a therapeutic target in diabetes. This evidence concerns the gene MAPK10 and diabetes mellitus.